Continuous administration of a drug for ‘prevention.' This is not a new concept.

Patients have been taking drugs to ‘manage’ their chronic condition for a long time, and drugs such as anticoagulants exist for the purpose of prevention.

This only became an issue after the concept of maintenance and adjuvant therapies were introduced in cancer treatment. The introduction has been less welcomed undoubtedly because of its high price. Everyone fears the risk of recurrence after being cured of cancer. Depending on the type of cancer, some cancers have a recurrence rate of up to 80%.

But in the era of high-priced drugs, prescribing the industry-leading high-priced anticancer d